Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      GSK launches Iodex UltraGel

      GSK launches Iodex UltraGel

      Medical Dialogues Bureau31 Jan 2020 1:23 PM IST
      New Delhi – GSK announced the launch of Iodex UltraGel, a new age clinically proven gel-based body pain solution. Backed by science, the new...
      Yamma buys $200-mln minority stake in Turkish drug maker Sanovel

      Yamma buys $200-mln minority stake in Turkish drug maker Sanovel

      Medical Dialogues Bureau30 Jan 2020 4:15 PM IST
      Istanbul: Luxembourg-based Yamma Investments agreed to buy a 30% stake in Turkish generic drug maker Sanovel for $200 million, the target company's...
      Mercks antibacterial med Dificid Gets FDA nod in Pediatric Indication

      Merck's antibacterial med Dificid Gets FDA nod in Pediatric Indication

      Medical Dialogues Bureau30 Jan 2020 3:50 PM IST
      Merck & Co., Inc announced that the FDA has granted approval to its new drug application ("NDA") and a supplemental NDA (sNDA) for its...
      Beijing drug store fined whooping $434,530 for hiking price of masks

      Beijing drug store fined whooping $434,530 for hiking price of masks

      Medical Dialogues Bureau30 Jan 2020 3:12 PM IST
      BEIJING: - A drug store in Beijing will be fined 3 million yuan ($434,530) for hiking the price of face masks by almost six times the online price...
      US offers 30 Billion US dollars more market to domestic pharma cos

      US offers 30 Billion US dollars more market to domestic pharma cos

      Medical Dialogues Bureau30 Jan 2020 3:10 PM IST
      Mumbai : Domestic pharma companies have the potential to grow their revenue from the US by almost five times at around USD 30 billion from USD 6.5...
      Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets

      Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets

      Medical Dialogues Bureau29 Jan 2020 1:25 PM IST
      Alembic Pharmaceuticals announces USFDA Final Approval for Azithromycin Tablets USP, 600 mg. Alembic Pharmaceuticals Limited (Alembic) has announced...
      Cipla gets USFDA EIR for Invagen manufacturing facility

      Cipla gets USFDA EIR for Invagen manufacturing facility

      Medical Dialogues Bureau29 Jan 2020 12:57 PM IST
      New Delhi: Homegrown pharma major Cipla on Tuesday said it has received a report from the US health regulator indicating closure of the inspection at...
      UK: NICE rejects Johnson and Johnson nasal spray for depression in NHS

      UK: NICE rejects Johnson and Johnson nasal spray for depression in NHS

      Medical Dialogues Bureau29 Jan 2020 12:38 PM IST
      The National Institute for Health and Care Excellence (NICE), which determines if a drug is included in Britain's National Healthcare System (NHS),...
      Hilleman Laboratories announces major leadership changes

      Hilleman Laboratories announces major leadership changes

      Medical Dialogues Bureau27 Jan 2020 3:09 PM IST
      New Delhi : The Board of Directors of Hilleman Laboratories today announced that Dr Davinder Gill will leave his current role as CEO of Hilleman...
      Ervaxx, Cardiff University enter collaboration to develop novel 
T-cell and T-cell receptor-based immunotherapeutics targeting 
Dark Antigens™

      Ervaxx, Cardiff University enter collaboration to develop novel 
T-cell and T-cell receptor-based immunotherapeutics targeting 
Dark Antigens™

      Medical Dialogues Bureau27 Jan 2020 2:31 PM IST
      London: Ervaxx™, a biotechnology company pioneering the use of Dark Antigens™ to develop T-cell receptor (TCR)-based immunotherapies and off-the-shelf...
      Roche wins approval for cancer drug Kadcyla in China

      Roche wins approval for cancer drug Kadcyla in China

      Medical Dialogues Bureau26 Jan 2020 10:15 AM IST
      Beijing/Zurich: Roche said on Wednesday China had approved the import of its Kadcyla drug for breast cancer, another win for the Swiss drugmaker in...
      DCGI releases list of Reference Products for conduct of BE Study, details

      DCGI releases list of Reference Products for conduct of BE Study, details

      Medical Dialogues Bureau25 Jan 2020 2:25 PM IST
      New Delhi: Through a recent notice, Drug Controller General of India has released the List of Products Permitted by DCG(I) and considered as Reference...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok